Great opportunity with 22nd Century Group. Potential reversal bounce off 200 SMA and positive divergence on MFI 14. Many things in the works right now with XXII. Phase 3 peer review soon, ANRPN from FDA on VLN tobacco, and increased institutional investment in Q4 2017.